VectivBio
VECT
#6120
Rank
โ‚ฌ0.93 B
Marketcap
14,83ย โ‚ฌ
Share price
0.00%
Change (1 day)
215.64%
Change (1 year)

Revenue for VectivBio (VECT)

Revenue in 2022: โ‚ฌ24.06 Million

According to VectivBio's latest financial reports the company's current revenue (TTM ) is โ‚ฌ24.06 Million. In 2022 the company made a revenue of โ‚ฌ24.06 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for VectivBio from 2019 to 2022

Annual revenue

Year Revenue Change
2022โ‚ฌ24.06 M
2021N/A
2020N/A
2019N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
โ‚ฌ0.12 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚ฌ19.22 M-20.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚ฌ0.95 B 3,861.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
โ‚ฌ0.59 B 2,366.68% Jersey